International Conference on Gastroenterology and Hepatitis Research
ICGHR
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest findings in hepatitis research, focusing on viral mechanisms and host interactions. Participants will discuss novel insights that could inform future therapeutic strategies.
SDG 3
SDG 4
This session will delve into the immunological aspects of hepatitis, examining how the immune system responds to viral infections. Researchers will present data on immune evasion strategies employed by hepatitis viruses.
SDG 3
SDG 4
This track will highlight cutting-edge antiviral therapies for hepatitis, including both established and experimental treatments. Discussions will focus on efficacy, safety, and the potential for combination therapies.
SDG 3
SDG 9
This session will provide an overview of the epidemiological trends in viral hepatitis, emphasizing global prevalence and risk factors. Participants will share data on population studies and public health implications.
SDG 3
SDG 4
This track will focus on the current state of vaccine development for hepatitis viruses, including challenges and breakthroughs. Researchers will discuss novel vaccine platforms and their potential impact on public health.
SDG 3
SDG 4
This session will explore recent advancements in diagnostic techniques for hepatitis and liver diseases. Emphasis will be placed on the role of molecular diagnostics and imaging technologies in improving patient outcomes.
SDG 3
SDG 9
This track will investigate the pathological changes associated with liver diseases, including hepatitis. Experts will discuss the underlying mechanisms of liver injury and the implications for treatment.
SDG 3
SDG 4
This session will review ongoing and completed clinical trials focused on hepatitis treatment protocols. Participants will analyze trial designs, outcomes, and the implications for clinical practice.
SDG 3
SDG 4
This track will emphasize the importance of patient-centered care in the management of hepatitis and liver diseases. Discussions will include strategies for improving patient engagement and adherence to treatment.
SDG 3
SDG 4
This session will explore integrative approaches that combine traditional and complementary therapies in hepatitis management. Researchers will present evidence on the efficacy and safety of these approaches.
SDG 3
SDG 4
This track will provide a forward-looking perspective on the future of gastroenterology research, particularly in the context of hepatitis. Participants will discuss emerging trends, technologies, and potential research collaborations.
SDG 3
SDG 4